LP533401 hcl Struktur

LP533401 hcl

Bezeichnung:LP533401 hcl

CAS-Nr1040526-12-2

Englisch Name:LP533401 hcl

CBNumberCB82731287

SummenformelC27H23ClF4N4O3

Molgewicht562.95

MOL-Datei1040526-12-2.mol

LP533401 hcl physikalisch-chemischer Eigenschaften

storage temp.	under inert gas (nitrogen or Argon) at 2-8°C
Löslichkeit	≥56.3 mg/mL in DMSO; insoluble in H2O; ≥19.4 mg/mL in EtOH
Aggregatzustand	solid
Farbe	Light yellow to yellow

Gefahreninformationscode (GHS)

LP533401 hcl Chemische Eigenschaften,Einsatz,Produktion Methoden

Biologische Aktivität
lp533401 hcl is an inhibitor of tph-1 [1].tryptophan hydroxylase-1 (tph-1) is an isoenzyme of tryptophan hydroxylase and the initial enzyme in gut- and lung-derived serotonin biosynthesis. tph-1 is mainly expressed in the gut and lung [2].lp533401 hcl is a tph-1 inhibitor. in rat rbl2h3 cells expressing tph1, lp533401 (1 μm) completely inhibited serotonin production. lp533401 reduced the activity of recombinant wild-type tph-1 by 70% by interacting with residues tyr235 and phe241 [1].in rodents, lp533401 orally administration was incapable of crossing the blood-brain barrier. in mice, lp533401 (250 mg/kg) dose-dependently reduced serum serotonin concentration by 30%. in ovariectomized female c57bl6/j mice, lp533401 (10, 100, 250 mg/kg for 28 days) increased bone mass and bone-formation parameters such as osteocalcin serum concentration, osteoblast numbers and bone formation rate. also, lp533401 dose-dependently decreased serum serotonin concentration but didn’t affect brain serotonin content. in ovariectomized female rats, lp533401 completely rescued the ovariectomy-induced osteopenia [1]. in transgenic sm22-5-htt+ mice overexpressing 5-ht transporter (5-htt) in smooth muscle cells and spontaneously developing pulmonary hypertension (ph), lp533401 (250 mg/kg for 21 days) significantly reduced lung and blood 5-ht levels, vascular ki67-positive cells, distal pulmonary artery muscularization, right ventricular (rv) hypertrophy and rv systolic pressure [2].
Einzelnachweise
[1]. yadav vk, balaji s, suresh ps, et al. pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. nat med, 2010, 16(3): 308-312.
[2]. abid s, houssaini a, chevarin c, et al. inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice. am j physiol lung cell mol physiol, 2012, 303(6): l500-508.

LP533401 hcl Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Send Inquriy